Panhematin Alternatives Compared
Panhematin (hemin) | Givlaari (givosiran) | Chlorpromazine |
|
---|
Panhematin (hemin) | Givlaari (givosiran) | Chlorpromazine |
|
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Porphyria. Panhematin may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Porphyria. Givlaari may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Hiccups, Light Sedation, Mania, Nausea/Vomiting, Opiate Withdrawal, Porphyria, Psychosis, Schizophrenia, Tetanus. Chlorpromazine may also be used for purposes not listed in this... View more |
Related suggestions Popular comparisons
|
|||||||||||||||
More about Panhematin (hemin) | More about Givlaari (givosiran) | More about Chlorpromazine | ||||||||||||||||
Ratings & Reviews | ||||||||||||||||||
Panhematin has an average rating of 10.0 out of 10 from a total of 1 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
Be the first to share your experience with this drug. |
Chlorpromazine has an average rating of 7.0 out of 10 from a total of 70 ratings on Drugs.com. 63% of reviewers reported a positive effect, while 26% reported a negative effect. |
||||||||||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||
View all Panhematin side effects |
View all Givlaari side effects |
View all Chlorpromazine side effects |
||||||||||||||||
Drug Class | ||||||||||||||||||
Generic Availability | ||||||||||||||||||
N/A |
Lower cost generic |
|||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Givlaari prices |
View all Chlorpromazine prices |
||||||||||||||||
Dosage Forms | ||||||||||||||||||
|
|
|
||||||||||||||||
Brand Names | ||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||
N/A |
6 hours |
31 hours |
||||||||||||||||
CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
Pregnancy Category | ||||||||||||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Category N
Not classified
See the full pregnancy warnings document. |
||||||||||||||||
Drug Interactions | ||||||||||||||||||
A total of 96 drugs are known to interact with Panhematin:
|
A total of 239 drugs are known to interact with Givlaari:
|
A total of 729 drugs are known to interact with Chlorpromazine:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
||||||||||||||||
Disease Interactions | ||||||||||||||||||
First Approval Date | ||||||||||||||||||
N/A |
November 20, 2019 |
November 20, 1957 |
||||||||||||||||
WADA Class View classifications | ||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||
More Information | ||||||||||||||||||
Patient Resources | ||||||||||||||||||
Professional Resources | ||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.